
Wyss Center appoints Dr. Craig Cook as new Head of Business Development and Licensing
Subscribe to our updates
-
25.08.2022
Consortium to develop fully implantable brain-computer interface to enable communication for people with paralysis
Project will push the boundaries of real-time brain-to-speech decoding with artificial intelligence algorithms and a miniaturized, wireless device.
Collaboration -
28.06.2022
Where I work: The shared dream of the ABILITY team
Project manager in Neuroengineering, Shenandoah Montamat, shares her hopes and dreams about the project she is leading, a brain computer interface (BCI) system for applications such as restoration of communication and movement for people with severe paralysis
Insight -
28.06.2022
Wyss Center joins Swiss life sciences cluster BioAlps
The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives, has joined BioAlps, the life sciences cluster for Western Switzerland.
Collaboration -
17.05.2022
Swiss science celebrates Hansjörg Wyss
Today, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great commitments to the science landscape in Switzerland.
Wyss Center -
05.05.2022
Where I work: Seeing the invisible
Advanced Microscopy Imaging Specialist, Ivana Gantar, explores the hidden microscopic world within mammalian brains using the latest lightsheet microscope technology
Insight -
22.03.2022
Completely locked-in man uses brain-computer interface to communicate
Two-year study paves the way for new technologies for people with severe paralysis
Technology -
24.02.2022
GliaPharm SA and the Wyss Center enter collaboration to develop new therapies for Alzheimer’s disease
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Collaboration -
25.01.2022
Alzheimer's disease: an alternative hypothesis based on synaptic alterations
New research suggests that targeting proteins essential to neurotransmission could be a promising alternative to treat Alzheimer's disease
Collaboration -
29.11.2021
Wyss Center and Inselspital Bern announce clinical trial for long-term brain monitoring technology
Early clinical study will assess safety and feasibility of the Epios™ subscalp recording leads in epilepsy patients
Technology -
01.11.2021
Wyss Center announces the appointment of Dr Richie Kohman as Chief Scientific Officer
Dr Kohman brings more than 15 years of research and industry experience in the development of transformative technologies for healthcare and society.
Wyss Center